Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Multiple people shot
Bakes son's iPad by mistake
Zegler defends Swift
Raises $4.4M in 48 hours
Executed for 1996 killings
Hardy cancels concerts
23 Indian soldiers missing
Meta to lay off employees
‘It was so childish’
Convicted of molesting boys
Petition to delay reopening
Legends of Coaching award
US automakers' sales rose
'Sadistic torturer' sentenced
US charges CN firms, execs
Sued for at least $23M
Pham battling turf toe
Out for season w/ torn ACL
'The truth always comes out'
Taking finance classes in jail
Available for free on TikTok
BET Hip-Hop Awards 2023
Joe Christopher dies
Steps away as manager
Ad-free subscription in EU?
Indicted on bribery charge
Cop charged w/ manslaughter
Wildfire smoke invades FL
Renewed for S4 at Hulu
Italy volcanic tremors
Calls Kelce 'Mr. Pfizer'
Undergoes elbow surgery
Ford makes 'strongest' offer?
Freed from Dubai prison
To release 1st solo album
US job openings rise
Grimes sues Elon Musk
Pledges to 'do better'
Epidemic of chronic illness
Calls for GOP debates to end
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
164,000 results
WISH-TV
6d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
13don MSN
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
Richmond
19h
FDA wants to regulate thousands of lab tests that have long skirted oversight
The Food and Drug Administration recently laid out a proposal to begin regulating laboratory medical tests, a ...
朝日新聞社4d
US approves Alzheimer’s drug that modestly slows disease
FDA approves much-debated Alzheimer’s drug panned by experts June 8, 2021 Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus ...
GEN
14h
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Morningstar analyst Karen Andersen, CFA, discusses a recent report by her firm about the challenges faced by biopharma with GEN Edge.
Forbes22d
What To Know About The Alzheimer’s Drug Leqembi
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
8d
After US approval, Japan approves Leqembi, its first Alzheimer's drug
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Daily Trojan22d
The USC researchers behind a newly approved treatment for Alzheimer’s
USC researchers played a key role in a new treatment for Alzheimer’s disease, the first with full approval to target a suspected root cause of the condition, offering hope to those with the disease ...
The Financial Times1mon
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
Business Wire14d
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker
BETHESDA, Md.--(BUSINESS WIRE)--Brain diagnostics innovator BrainScope announced today a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s current Series B ...
WTOP News20d
New Treatments for Alzheimer’s Disease
For anyone who has or knows someone who has Alzheimer’s disease, a progressive and irreversible form of dementia that’s ultimately deadly, it can sometimes be difficult to find hope.
8d
After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices